carvedilol has been researched along with natriuretic peptide, c-type in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Heringer-Walther, S; Moreira, Mda C; Schultheiss, HP; Ventura, TM; Walther, T; Wang, Y; Wessel, N | 1 |
1 other study(ies) available for carvedilol and natriuretic peptide, c-type
Article | Year |
---|---|
Does the C-type natriuretic peptide have prognostic value in chagas disease and other dilated cardiomyopathies?
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Chagas Disease; Echocardiography; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Middle Aged; Natriuretic Peptide, C-Type; Predictive Value of Tests; Prognosis; Propanolamines; Stroke Volume; Survival Analysis; Ventricular Dysfunction, Left | 2006 |